101 related articles for article (PubMed ID: 28655792)
21. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
[TBL] [Abstract][Full Text] [Related]
22. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV
Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009
[TBL] [Abstract][Full Text] [Related]
23. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
[TBL] [Abstract][Full Text] [Related]
25. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
26. C646 modulates inflammatory response and antibacterial activity of macrophage.
Fang F; Li G; Jing M; Xu L; Li Z; Li M; Yang C; Liu Y; Qian G; Hu X; Li G; Xie Y; Feng C; Li X; Pan J; Li Y; Feng X; Li Y
Int Immunopharmacol; 2019 Sep; 74():105736. PubMed ID: 31302452
[TBL] [Abstract][Full Text] [Related]
27. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
29. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.
Wang D; Kon N; Lasso G; Jiang L; Leng W; Zhu WG; Qin J; Honig B; Gu W
Nature; 2016 Oct; 538(7623):118-122. PubMed ID: 27626385
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3.
Vincek AS; Patel J; Jaganathan A; Green A; Pierre-Louis V; Arora V; Rehmann J; Mezei M; Zhou MM; Ohlmeyer M; Mujtaba S
Molecules; 2018 Aug; 23(8):. PubMed ID: 30072621
[TBL] [Abstract][Full Text] [Related]
31. New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53.
Sorriento D; Del Giudice C; Bertamino A; Ciccarelli M; Gomez-Monterrey I; Campiglia P; Novellino E; Illario M; Trimarco B; De Luca N; Iaccarino G
Br J Cancer; 2015 Jan; 112(1):77-85. PubMed ID: 25422906
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
[TBL] [Abstract][Full Text] [Related]
33. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
34. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.
Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384
[TBL] [Abstract][Full Text] [Related]
35. Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201.
Jeay S; Ferretti S; Holzer P; Fuchs J; Chapeau EA; Wartmann M; Sterker D; Romanet V; Murakami M; Kerr G; Durand EY; Gaulis S; Cortes-Cros M; Ruetz S; Stachyra TM; Kallen J; Furet P; Würthner J; Guerreiro N; Halilovic E; Jullion A; Kauffmann A; Kuriakose E; Wiesmann M; Jensen MR; Hofmann F; Sellers WR
Cancer Res; 2018 Nov; 78(21):6257-6267. PubMed ID: 30135191
[TBL] [Abstract][Full Text] [Related]
36. Acetylation of p53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway.
Yun T; Yu K; Yang S; Cui Y; Wang Z; Ren H; Chen S; Li L; Liu X; Fang M; Jiang X
J Biol Chem; 2016 Apr; 291(14):7386-95. PubMed ID: 26851285
[TBL] [Abstract][Full Text] [Related]
37. Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.
Kusio-Kobialka M; Wolanin K; Podszywalow-Bartnicka P; Sikora E; Skowronek K; McKenna SL; Ghizzoni M; Dekker FJ; Piwocka K
Apoptosis; 2012 Sep; 17(9):950-63. PubMed ID: 22696202
[TBL] [Abstract][Full Text] [Related]
38. Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway.
Zhou Y; Que KT; Zhang Z; Yi ZJ; Zhao PX; You Y; Gong JP; Liu ZJ
Cancer Med; 2018 Aug; 7(8):4012-4022. PubMed ID: 29989329
[TBL] [Abstract][Full Text] [Related]
39. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
40. Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis.
Rai R; Sun T; Ramirez V; Lux E; Eren M; Vaughan DE; Ghosh AK
J Cell Mol Med; 2019 Apr; 23(4):3026-3031. PubMed ID: 30710427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
